Alex S. Keuroghlian|Sari L. Reisner|Jaclyn M. White|Roger D. Weiss
Substance use and treatment of substance use disorders in a community sample of transgender adults
Fenway Health|Harvard University|Fenway Health|Harvard University|Yale University|Fenway Health|McLean Hospital|Harvard University
transgender people elevated substance use prevalence compared us general population however studies comprehensively examined relationship psychosocial risk factors substance use substance use disorder sud treatment among maletofemale mtf femaletomale ftm transgender adultssecondary data analysis 2013 communitybased survey transgender adults massachusetts n452 conducted adjusted multivariable logistic regression models fit examine relationship four risk factor domains sud treatment history recent substance use 1 demographics 2 genderrelated characteristics 3 mental health 4 sociostructural factors adjusted odds ratios aor 95 confidence intervals 95 ci estimatedten percent sample reported lifetime sud treatment factors associated significant increase odds lifetime sud treatment alongside recent substance use p005 1 older age aor102 95 ci101104 higher educational attainment aor359 95 ci235550 low income aor058 95 ci039086 2 mtf identity aor303 95 ci195467 genderaffirming medical care aor199 95 ci132300 3 intimate partner violence aor168 95 ci113249 posttraumatic stress disorder aor256 95 ci169388 depression aor230 95 ci158335 mental health treatment aor165 95 ci111245 4 discrimination aor190 95 ci122295 unstable housing aor180 95 ci121267 sex work aor248 95 ci124495substance use sud treatment among transgender adults associated demographic genderrelated mental health sociostructural risk factors studies warranted identify sud treatment barriers integrate sud treatment psychosocial structural interventions diverse spectrum transgender adults